Northwestern Mutual Wealth Management’s Ascendis Pharma A/S ASND Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$229	Sell	1 -9	-90%	-$2.02K	﹤0.01%	3927
2025 Q4	$2.13K	Buy	10 +4	+67%	+$826	﹤0.01%	3473
2025 Q3	$1.19K	Buy	+6	New	+$1.12K	﹤0.01%	3508

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northwestern Mutual Wealth Management's ASND Position: Q1 2026 in Review

Northwestern Mutual Wealth Management reduced its Ascendis Pharma A/S (ASND) stake by 90% in Q1 2026, selling an estimated $2.02K and leaving 1 share worth $229. The position accounts for ﹤0.01% of the portfolio, ranked #3927.

Northwestern Mutual Wealth Management first reported a position in ASND in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.13K in Q4 2025. 273 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

Northwestern Mutual Wealth Management held 1 share of Ascendis Pharma A/S worth $229 as of Q1 2026.
Northwestern Mutual Wealth Management sold 9 Ascendis Pharma A/S shares in Q1 2026, an estimated $2.02K.
Ascendis Pharma A/S made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3927 holding.
Northwestern Mutual Wealth Management first reported a position in Ascendis Pharma A/S in Q3 2025 and has held it in 3 quarters since.
Northwestern Mutual Wealth Management's Ascendis Pharma A/S position peaked at $2.13K in Q4 2025.
273 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.